However, pDCs from SLE patients had increased IFNα production when stimulated with a TLR7 agonist, but reduced IFNα production in these cells when stimulated with a TLR9 agonist (Figure 1) (55, 56). Here, TLR9 is linked to systemic lupus erythematosus.